-
Murali, R, Zannino, D, Synnott, M, McCarthy, SW, Thompson, JF, Scolyer, RA.
Clinical and pathological features of metastases of primary cutaneous desmoplastic melanoma.
Histopathology
58(6)
:
886 -895
2011
view publication
-
Price, TJ, Zannino, D, Wilson, K, Simes, J, Van Hazel, GA, Robinson, BA, Broad, A, Ganju, V, Ackland, SP, Tebbutt, NC.
Geriatric subgroup of AGITG MAX trial: International randomized phase III trial of capecitabine (C), bevacizumab (B), and mitomycin C (M) in first-line metastatic colorectal cancer (CRC)..
Journal of Clinical Oncology
29(4_suppl)
:
510 -510
2011
view publication
-
Drury, PL, Ting, R, Zannino, D, Ehnholm, C, Flack, J, Whiting, M, Fassett, R, Ansquer, J-C, Dixon, P, Davis, TME, et al.
Estimated glomerular filtration rate and albuminuria are independent predictors of cardiovascular events and death in type 2 diabetes mellitus: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study.
Diabetologia
54(1)
:
32 -43
2011
view publication
-
Murali, R, Zannino, D, Synnott, M, McCarthy, S, Thompson, J, Scolyer, R.
27. Pathological features of metastases from primary cutaneous desmoplastic melanoma.
Pathology
43:
s97
2011
view publication
-
Tebbutt, NC, Wilson, K, Gebski, VJ, Cummins, MM, Zannino, D, van Hazel, GA, Robinson, B, Broad, A, Ganju, V, Ackland, SP, et al.
Capecitabine, Bevacizumab, and Mitomycin in First-Line Treatment of Metastatic Colorectal Cancer: Results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study.
Journal of Clinical Oncology
28(19)
:
3191 -3198
2010
view publication